Outi M Keinänen (Outi Keinänen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Molecular pharmaceutics

Nature protocols

Proceedings of the National Academy of Sciences of the United States of America

Bioconjugate chemistry

Hunter College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hunter College May 15 2018

United States

Research Fellow :: Department of Chemistry

Publications

Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics 21 (3) (2024)
Samantha M Sarrett, Cindy Rodriguez, Samantha Delaney, Meena M Hosny, Joni Sebastiano, Ana Santos-Coquillat, Outi M Keinänen, Lukas M Carter, Kristin J Lastwika, Paul D Lampe, Brian M Zeglis
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular pharmaceutics (2024)
Outi M Keinänen, Samantha M Sarrett, Samantha Delaney, Cindy Rodriguez, Eric J Dayts, Emily Capone, Frederic Sauniere, Rodolfo Ippoliti, Gianluca Sala, Stefano Iacobelli, Brian M Zeglis
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET. Molecular pharmaceutics (2023)
Douglas S MacPherson, Dobeen Hwang, Samantha M Sarrett, Outi M Keinänen, Cindy Rodriguez, Christoph Rader, Brian M Zeglis
Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate. Molecular pharmaceutics (2022)
Samantha M Sarrett, Cindy Rodriguez, Grzegorz Rymarczyk, Meena M Hosny, Outi M Keinänen, Samantha Delaney, Sarah Thau, Benjamin A Krantz, Brian M Zeglis
Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates. Bioconjugate chemistry 33 (9) (2022)
Surachet Imlimthan, You Cheng Khng, Outi M Keinänen, Wenzhong Zhang, Anu J Airaksinen, Mauri A Kostiainen, Brian M Zeglis, Hélder Almeida Santos, Mirkka P Sarparanta
A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma. Small (Weinheim an der Bergstrasse, Germany) 17 (18) (2021)
Samantha M Sarrett, Outi M Keinänen, Eric J Dayts, Guillaume Dewaele-Le Roi, Cindy Rodriguez, Kathryn E Carnazza, Brian M Zeglis
Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy. Nature protocols 16 (7) (2021)
Kimberly Fung, Delphine Vivier, Outi M Keinänen, Elaheh Khozeimeh Sarbisheh, Eric W Price, Brian M Zeglis
89Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe. Molecules (Basel, Switzerland) 25 (10) (2020)
Outi M Keinänen, Kimberly Fung, James M Brennan, Nicholas Zia, Matt Harris, Ellen van Dam, Colin Biggin, Amos Hedt, Jon Stoner, Paul S Donnelly, Jason S Lewis, Brian M Zeglis
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
Kimberly Fung, Sai Kiran Sharma, Outi M Keinänen, Kara Long Roche, Jason S Lewis, Brian M Zeglis
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer. Molecular pharmaceutics 17 (8) (2020)
Gu Xiao, George K Annor, Kimberly Fung, Outi M Keinänen, Brian M Zeglis, Jill Bargonetti
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide. Molecular pharmaceutics 18 (1) (2020)

Outi M Keinänen.css-eqlu8i{font-size:small;padding-left:4px;} (Outi Keinänen)

Publication Activity (10 Years)

Top Topics

Top Venues

Outi M Keinänen (Outi Keinänen)